2022-137-E-Health-Duke University - Charlene Wong-Federal awarding agency

Browse Search

14 Revised 9/8/2021 https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited -english- proficiency/fact-sheet-guidance/index.html and https://www.lep.gov. • For information on your specific legal obligations for serving qualif ied individuals with disabilities , including providing program access, reasonable modifications, and taking appropriate steps to provide effective communication, see http://www.hhs.gov/ocr/civilrights/understanding/disability/index.html. • HHS funded health and education programs must be administered in an environment free of sexual harassment, see https://www.hhs.gov/civil-rights/for- individuals/sex-discrimination/index.html. • For guidance on administering your project in compliance with applicable federal religious nondiscrimination laws and applicable federal conscience protect ion and associated anti-discrimination laws , see https://www.hhs.gov/conscience/conscience- protections/index.html and https://www.hhs.gov/conscience/religious- freedom/index.html. Recipients should review and comply with the reporting and review activities regarding accessibility requests outlined in Attachment G, to these Standard Terms and Conditions. 26. Fraud, Waste, and Abuse. The HHS Office of the Inspector General (OIG) maintains a toll- free number (1-800-HHS-TIPS [1-800-447-8477]) for receiving information conc erning fraud, waste, or abuse under grants and cooperative agreements as well as the HHS OIG website at https://oig.hhs.gov/fraud/report-fraud/index.asp. Information also may be submitted by email to hhstips@oig.hhs.gov or by mail to Office of the Inspector General, U.S. Department of Health & Human Services, Attn: HOTLINE, 330 Independence Ave., SW, Washington, DC 20201. Such reports are treated as sensitive material and submitters may decline to give their names if they choose to remain anonymous. 27. Human Subjects Protection. If applicable to Recipient’s program, the Recipient bears ultimate responsibility for protecting human subjects under the awa rd, including human subjects at all sites, and for ensuring that a Federal-wide A ssurance (FWA) approved by the Office for Human Research Protections (OHRP ) and certification of Institutional Review Board (IRB) review and approval have been obtained before human subjects research can be conducted at each collaborating site . For more information about OHRP, FWA, and IRBs, please see the following link: http://www.hhs.gov/ohrp/index.html. Recipients may not draw funds from the payment system, request funds from the paying office, or make obligations against Federal funds for research involving human subjects at any site engaged in nonexempt research for any period not covered by both an OHRP -approved assuranc e and IRB approval consistent with 45 CFR Part 46. Costs associated with IRB review of huma n research protocols are not allowable as direct charges under grants and cooperative agr eements unless such costs are not covered by the organization’s indirect cos t rate. HHS requires Recipients and others involved in grant/cooperative agreement-supported research to take appropriate actions to protect the confidentiality of inf ormation about and the privacy of individuals participating in the research. Investigators, IRBs, and other appropriate DocuSign Envelope ID: 7832B0E4-F34E-430E-A3C2-1A6A14F29307